Dynamic BH3 profiling identifies active BH3 mimetic combinations in non-small cell lung cancer
Danielle S. Potter(Harvard University), Anthony Letai(Dana-Farber Cancer Institute)
Cited by 36
Related Papers
MCL-1–dependent leukemia cells are more sensitive to chemotherapy than BCL-2–dependent counterparts
|The Journal of Cell Biology|2009|88
Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma
|Nature Communications|2023|21
Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cells
|Cell Death and Disease|2023|18